Thrombolytic therapy is available for the 85% of strokes that are caused when a blood vessel in the brain is blocked by a clot (ischemic stroke). A substance called tPA (tissue plasminogen activator) is administered intravenously during the first three hours after the stroke. By dissolving the blood clot, tPA restores blood flow to the brain and significantly improves a patient's chances of recovery. This medication is called a thrombolytic drug because it helps to dissolve (lyse) blood clots (thrombi) that are blocking blood flow to the brain.







